$1.09
0.1921.1%
At close: Aug 14, 5:00 PM EST
$1.08
-0.01-0.92%
After Hours: Aug 14, 7:59 PM EST
Inovio Pharmaceuticals Inc Earnings Estimates
INONASDAQ
Earnings: Q2 2026 Earnings were released on Wed Aug 12th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 4 days agoClick to view the webcast
Inovio Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:INO
Inovio Pharmaceuticals (INO) is scheduled to report Q3 earnings on November 9, 2026. Analysts estimate EPS of $-0.23 and quarterly revenue of $3.63M.
In the most recent quarter (Q2), Inovio Pharmaceuticals reported EPS of $-0.07, beating estimates of $-0.25 by 0.72%. Revenue came in at $0, missing the estimate of $400K by 1%.
Inovio Pharmaceuticals has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Inovio Pharmaceuticals has averaged an EPS surprise of 0.3% and a revenue surprise of 1%.
Earnings Date
Nov 9
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$3.63M
Annual Revenue
–
as of Jun 30
Inovio Pharmaceuticals Earnings History
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
Inovio Pharmaceuticals (INO) Earnings Per Share
The chart below shows Inovio Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Inovio Pharmaceuticals (INO) Revenue
The chart below shows Inovio Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?
Inovio Pharmaceuticals (INO) is scheduled to report earnings on November 9, 2026. The last reported earnings were for reported on August 12, 2026 for Q2.
What were the latest earnings per share (EPS) for Inovio Pharmaceuticals (NASDAQ:INO)?
The Actual EPS was $-0.07, which beat the estimate of $-0.25.
What were Inovio Pharmaceuticals’s (NASDAQ:INO) revenues?
The Actual Revenue was $0, which missed the estimate of $400K.
